368 related articles for article (PubMed ID: 8087425)
1. c-Myc does not require max for transcriptional activity in PC-12 cells.
Ribon V; Leff T; Saltiel AR
Mol Cell Neurosci; 1994 Jun; 5(3):277-82. PubMed ID: 8087425
[TBL] [Abstract][Full Text] [Related]
2. Gene-regulatory properties of Myc helix-loop-helix/leucine zipper mutants: Max-dependent DNA binding and transcriptional activation in yeast correlates with transforming capacity.
Crouch DH; Fisher F; Clark W; Jayaraman PS; Goding CR; Gillespie DA
Oncogene; 1993 Jul; 8(7):1849-55. PubMed ID: 8510929
[TBL] [Abstract][Full Text] [Related]
3. Determination of sequences responsible for the differential regulation of Myc function by delta Max and Max.
Västrik I; Mäkelä TP; Koskinen PJ; Alitalo K
Oncogene; 1995 Aug; 11(3):553-60. PubMed ID: 7630640
[TBL] [Abstract][Full Text] [Related]
4. Both the helix-loop-helix and the leucine zipper motifs of c-Myc contribute to its dimerization specificity with Max.
Davis LJ; Halazonetis TD
Oncogene; 1993 Jan; 8(1):125-32. PubMed ID: 8423990
[TBL] [Abstract][Full Text] [Related]
5. Mutational analysis of Max: role of basic, helix-loop-helix/leucine zipper domains in DNA binding, dimerization and regulation of Myc-mediated transcriptional activation.
Reddy CD; Dasgupta P; Saikumar P; Dudek H; Rauscher FJ; Reddy EP
Oncogene; 1992 Oct; 7(10):2085-92. PubMed ID: 1408152
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the Myc and Max interaction specificity with lambda repressor-HLH domain fusions.
Marchetti A; Abril-Marti M; Illi B; Cesareni G; Nasi S
J Mol Biol; 1995 May; 248(3):541-50. PubMed ID: 7752223
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max.
Amati B; Dalton S; Brooks MW; Littlewood TD; Evan GI; Land H
Nature; 1992 Oct; 359(6394):423-6. PubMed ID: 1406955
[TBL] [Abstract][Full Text] [Related]
8. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation.
Lüscher B; Larsson LG
Oncogene; 1999 May; 18(19):2955-66. PubMed ID: 10378692
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Mxi1 inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex.
Wu S; Peña A; Korcz A; Soprano DR; Soprano KJ
Oncogene; 1996 Feb; 12(3):621-9. PubMed ID: 8637719
[TBL] [Abstract][Full Text] [Related]
10. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
Gupta K; Anand G; Yin X; Grove L; Prochownik EV
Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
[TBL] [Abstract][Full Text] [Related]
11. Insights into the mechanism of heterodimerization from the 1H-NMR solution structure of the c-Myc-Max heterodimeric leucine zipper.
Lavigne P; Crump MP; Gagné SM; Hodges RS; Kay CM; Sykes BD
J Mol Biol; 1998 Aug; 281(1):165-81. PubMed ID: 9680483
[TBL] [Abstract][Full Text] [Related]
12. Regulation of transcription factors c-Myc, Max, and c-Myb by casein kinase II.
Bousset K; Oelgeschläger MH; Henriksson M; Schreek S; Burkhardt H; Litchfield DW; Lüscher-Firzlaff JM; Lüscher B
Cell Mol Biol Res; 1994; 40(5-6):501-11. PubMed ID: 7735324
[TBL] [Abstract][Full Text] [Related]
13. Mad1 expression in the absence of differentiation: effect of cAMP on the B-lymphoid cell line Reh.
Naderi S; Blomhoff HK
J Cell Physiol; 1999 Jan; 178(1):76-84. PubMed ID: 9886493
[TBL] [Abstract][Full Text] [Related]
14. Evolutionary relationships and functional conservation among vertebrate Max-associated proteins: the zebra fish homolog of Mxi1.
Schreiber-Agus N; Chin L; Chen K; Torres R; Thomson CT; Sacchettini JC; DePinho RA
Oncogene; 1994 Nov; 9(11):3167-77. PubMed ID: 7936639
[TBL] [Abstract][Full Text] [Related]
15. DNA binding by N- and L-Myc proteins.
Ma A; Moroy T; Collum R; Weintraub H; Alt FW; Blackwell TK
Oncogene; 1993 Apr; 8(4):1093-8. PubMed ID: 8455937
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of Max and role of c-Myc during erythroid and myelomonocytic differentiation of K562 cells.
Delgado MD; Lerga A; Cañelles M; Gómez-Casares MT; León J
Oncogene; 1995 Apr; 10(8):1659-65. PubMed ID: 7731722
[TBL] [Abstract][Full Text] [Related]
17. Myc drives apoptosis in PC12 cells in the absence of Max.
Wert M; Kennedy S; Palfrey HC; Hay N
Oncogene; 2001 Jun; 20(28):3746-50. PubMed ID: 11439337
[TBL] [Abstract][Full Text] [Related]
18. Regulation of human ornithine decarboxylase expression following prolonged quiescence: role for the c-Myc/Max protein complex.
Peña A; Wu S; Hickok NJ; Soprano DR; Soprano KJ
J Cell Physiol; 1995 Feb; 162(2):234-45. PubMed ID: 7822433
[TBL] [Abstract][Full Text] [Related]
19. Differential effects by Mad and Max on transformation by cellular and viral oncoproteins.
Cerni C; Bousset K; Seelos C; Burkhardt H; Henriksson M; Lüscher B
Oncogene; 1995 Aug; 11(3):587-96. PubMed ID: 7630643
[TBL] [Abstract][Full Text] [Related]
20. Identification of casein kinase II phosphorylation sites in Max: effects on DNA-binding kinetics of Max homo- and Myc/Max heterodimers.
Bousset K; Henriksson M; Lüscher-Firzlaff JM; Litchfield DW; Lüscher B
Oncogene; 1993 Dec; 8(12):3211-20. PubMed ID: 8247525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]